We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

62 hedge funds and large institutions have $2.34M invested in Envoy Medical Warrant in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

3% more funds holding

Funds holding: 60 → 62 (+2)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

19% less capital invested

Capital invested by funds: $2.9M → $2.34M (-$561K)

Holders
62
Holders Change
+2
Holders Change %
+3.33%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
8
Closed
6
Calls
$6.24M
Puts
–
Net Calls
+$6.24M
Net Calls Change
-$24K

Top Buyers

Rank Fund Capital Flow
1
BCL
Bracebridge Capital LLC
Massachusetts
+$14.7K
2
SG
StoneX Group
New York
+$12.8K
3
SRF
Silver Rock Financial
California
+$11.8K
4
BFM
Boothbay Fund Management
New York
+$6.79K
5
ETH
Exos TFP Holdings
New York
+$3.93K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$112K
2
Man Group
Man Group
United Kingdom
-$15.7K
3
BCM
BlueCrest Capital Management
Jersey
-$7.6K
4
RA
Ramius Advisors
New York
-$6.6K
5
CS
Clear Street
New York
-$4.09K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$1.21M +$6.79K +120,800 New
SCM
2
Segantii Capital Management
Hong Kong
$503K – – –
AC
3
Athos Capital
Hong Kong
$333K – – –
Nomura Holdings
4
Nomura Holdings
Japan
$31.7K -$234 -4,166 -0.7%
AC
5
Aristeia Capital
Connecticut
$31.4K – – –
DC
6
Diametric Capital
Massachusetts
$17.4K – – –
ETH
7
Exos TFP Holdings
New York
$13.5K +$3.93K +70,000 +24%
PAMP
8
Polar Asset Management Partners
Ontario, Canada
$11.2K – – –
PC
9
Periscope Capital
Ontario, Canada
$11.1K – – –
BNP Paribas Financial Markets
10
BNP Paribas Financial Markets
France
$9.97K – – –
BCL
11
Bracebridge Capital LLC
Massachusetts
$9.86K +$14.7K +262,156 New
Man Group
12
Man Group
United Kingdom
$9.84K -$15.7K -279,455 Closed
SCM
13
Shaolin Capital Management
Florida
$8K – – –
AC
14
Antara Capital
New York
$7.64K – – –
Jane Street
15
Jane Street
New York
$7.34K +$3 +56 +0%
SG
16
StoneX Group
New York
$7.08K +$12.8K +228,233 New
WA
17
Whitebox Advisors
Minnesota
$6.92K – – –
SRF
18
Silver Rock Financial
California
$6.5K +$11.8K +209,849 New
SC
19
Sculptor Capital
New York
$6.41K -$141 -2,500 -1%
MCM
20
Moore Capital Management
New York
$6.37K – – –
VI
21
Vestcor Inc
New Brunswick, Canada
$6K – – –
KL
22
KIM LLC
Kansas
$5.87K – – –
RCM
23
Radcliffe Capital Management
Pennsylvania
$5.87K – – –
QGA
24
Q Global Advisors
Texas
$5K – – –
RIA
25
RP Investment Advisors
Ontario, Canada
$5K – – –
1
2 3

COCHW Hedge Fund Activity: Q1 2023 in Review

62 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q1 2023, worth a combined $2.34M — down 19% from $2.9M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new COCHW positions and 6 closed out — a net gain of 2 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Bracebridge Capital LLC, opening a new position worth an estimated $14.7K. The largest seller was Mangrove Partners, exiting entirely with an estimated $112K sold.

  • 62 institutional investors held Envoy Medical Warrant (COCHW) as of Q1 2023, up from 60 in Q4 2022.
  • Funds reported $2.34M of Envoy Medical Warrant stock for Q1 2023, down 19% quarter-over-quarter.
  • 8 funds opened new Envoy Medical Warrant positions in Q1 2023 and 6 closed out, a net change of +2 holders.
  • The largest Envoy Medical Warrant buyer in Q1 2023 was Bracebridge Capital LLC, an estimated $14.7K added.
  • The largest Envoy Medical Warrant seller in Q1 2023 was Mangrove Partners, an estimated $112K sold.

Based on aggregated 13F filings for Q1 2023.